Abou-Jawde RM, Mekhail T, Adelstein DJ, Rybicki LA, Mazzone PJ, Caroll MA, Rice TW. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 2005 Jul;128(1):250-255
Absi A, Adelstein DJ. Esophageal cancer. In: Carey WD, ed. The Cleveland Clinic disease management project [electronic resource]. Cleveland, OH: Cleveland Clinic Center for Continuing Education, 2005.
Adelstein DJ. Concurrent chemoradiotherapy: Impact on survival and organ preservation. In: Adelstein DJ, ed. Squamous cell head and neck cancer : recent clinical progress and prospects for the future. Totowa, N.J.: Humana Press, 2005. Chapter 13. p. 187-195.
Adelstein DJ. Squamous cell head and neck cancer: recent clinical progress and prospects for the future. Totowa, N.J.: Humana Press; 2005. 358 p. (Current Clinical Oncology).
Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Zuccaro G, Vargo JJ, Dumot JA, Carroll MA. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity. American Journal of Clinical Oncology 2007 Apr;30(2):172-180.
Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. American Journal of Gastroenterology 2004 Nov;99(11):2098-2106.
Bronner MP. Inflammatory disorders of the esophagus. In: Odze RD, Goldblum JR, Crawford JM, eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia: Saunders, 2004. Chapter 7. p. 121-142.
Bronner MP, Geisinger KR. The esophagus. In: Silverberg SG, ed. Silverberg's principles and practice of surgical pathology and cytopathology. 4th ed. [Edinburgh]: Churchill Livingstone Elsevier, 2006. Volume 2. Chapter 24. p. 1281-1319.
Ercan S, Rice TW, Murthy SC, Rybicki LA, Blackstone EH. Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? Journal of Thoracic and Cardiovascular Surgery 2005 Mar;129(3):623-631.
Fahmy M, Skacel M, Gramlich TL, Brainard JA, Rice TW, Goldblum JR, Connor JT, Casey G, Legator MS, Tubbs RR, Falk GW. Chromosomal gains and genomic loss of p53 and p16 genes in Barretts esophagus detected by fluorescence in situ hybridization of cytology specimens. Modern Pathology 2004 May;17(5):588-596.
Falk GW, Skacel M, Gramlich TL, Casey G, Goldblum JR, Tubbs RR. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: A pilot feasibility study. Gastrointestinal Endoscopy 2004 Aug;60(2):280-284.
Falk GW. Role of Helicobacter pylori in GERD. In: Castell DO, Richter JE, eds. The esophagus. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Chapter 24. p. 451-459.
Falk GW. Barrett's esophagus-Is it bad for your health? American Journal of Gastroenterology 2005 Dec;100(12):2622-2623.
Falk GW, Lever DS. Peptic ulcer disease. In: Stoller JK, Michota FA, Jr., Mandell BF, eds. The Cleveland Clinic intensive review of internal medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005. Chapter 58. p. 703-717.
Falk GW, Ehrlich L, Fendrick AM, Fennerty MB, Gold B, Vakil N, van Amerongen D, Wyatt D. Pitfalls, pearls, and practicalities in the diagnosis of Helicobacter pylori infection. Cleveland Clinic Journal of Medicine 2005 May;(72 Suppl 2):S14-S21.
Falk GW. Chest pain, non-cardiac. In: Johnson LR, ed. Encyclopedia of gastroenterology. Amsterdam; Boston: Elsevier Academic Press, 2004. Volume 1. p. 295-299.
Falk GW. Diagnosis and surveillance of Barretts esophagus. In: Ginsberg GC, ed. Clinical gastrointestinal endoscopy. Philadelphia: Philadelphia: Elsevier Saunders, 2005. Chapter 28. p. 397-415.
Falk GW, ed. Testing for Helicobacter pylori: why it still matters, how it has evolved. Cleveland: The Cleveland Clinic Foundation, 2005 (Cleveland Clinic Journal of Medicine 72 Suppl 2:S1-S21.)
Falk GW, Thota PN, Richter JE, Connor JT, Wachsberger DM. Barrett's esophagus in women: Demographic features and progression to high-grade dysplasia and cancer. Clinical Gastroenterology and Hepatology 2005 Nov;3(11):1089-1094.
Falk GW. Night vision goggles for surveillance of Barrett's esophagus: a paradigm shift is coming! Gastroenterology 2007 Mar;132(3):1189-1191.
Falk GW, Fennerty MB, Rothstein RI. AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease. Gastroenterology 2006 Oct;131(4):1315-1336.
Falk GW. Surveillance of Barrett's esophagus. In: Sharma P, Sampliner R, eds. Barrett's esophagus and esophageal adenocarcinoma. 2nd ed. Malden, Mass.: Oxford: Blackwell Pub, 2006. Chapter 12. p. 107-123.
Falk GW. Turning an idea into a grant. Gastrointestinal Endoscopy 2006 Dec;64(6 Suppl):S11-S13.
Falk GW, Goldblum JR. Extent of low-grade dysplasia in Barrett's esophagus: Is it useful for risk stratification? American Journal of Gastroenterology 2007 Mar;102(3):494-496.
Nonevski I, Fiocchi C, Falk GW. Eosinophilic esophagitis: new insights into an emerging disease. Gastroenterology 2006 Dec;131(6):2018-2020.
Chak A, Ochs-Balcom H, Falk G, Grady WM, Kinnard M, Willis JE, Elston R, Eng C. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiology, Biomarkers & Prevention 2006 Sep;15(9):1668-1673.
Chak A, Faulx A, Eng C, Grady W, Kinnard M, Ochs-Balcom H, Falk G. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer 2006 Nov 1;107(9):2160-2166.
Glickman JN, Ormsby AH, Gramlich TL, Goldblum JR, Odze RD. Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus. Human Pathology 2005 Jan;36(1):58-65.
Goldblum JR, Lee RG. Esophagus. In: Mills SE, ed. Sternbergs diagnostic surgical pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Volume 2. Chapter 31. p. 1399-1433.
Guardino JM, Khandwala F, Lopez R, Wachsberger DM, Richter JE, Falk GW. Barrett's esophagus at a tertiary care center: Association of age on incidence and prevalence of dysplasia and adenocarcinoma. American Journal of Gastroenterology 2006 Oct;101(10):2187-2193.
Imam H, Shay S, Ali A, Baker M. Bolus transit patterns in healthy subjects: a study using simultaneous impedance monitoring, videoesophagram, and esophageal manometry. American Journal of Physiology Gastrointestinal and Liver Physiology 2005 May;288(5):G1000-
Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, Butler RS, Esclamado RM. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head & Neck 2006 Sep;28(9):808-812.
Little SG, Rice TW, Bybel B, Mason DP, Murthy SC, Falk GW, Rybicki LA, Blackstone EH. Is FDG-PET indicated for superficial esophageal cancer? European Journal of Cardio-Thoracic Surgery 2007 May;31(5):792-797.
Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell DO. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006 Oct;55(10):1398-1402.
Mendelin JE, Goldblum JR. Histology of Barrett's esophagus: metaplasia and dysplasia. In: Sharma P, Sampliner R, eds. Barrett's esophagus and esophageal adenocarcinoma. 2nd ed. Malden, Mass.: Oxford: Blackwell Pub, 2006. Chapter 10. p. 92-100.
Murthy SC, Rice TW. Esophageal perforation. In: Yang SC, Cameron DE, eds. Current therapy in thoracic and cardiovascular surgery. Philadelphia: Mosby, 2004. p. 81-86.
Nayar DS, Khandwala F, Achkar E, Shay SS, Richter JE, Falk GW, Soffer EE, Vaezi MF. Esophageal manometry: assessment of interpreter consistency. Clinical Gastroenterology and Hepatology 2005 Mar;3(3):218-224.
Odze RD, Goldblum JR. Low-grade dysplasia in Barrett's esophagus. Clinical Gastroenterology and Hepatology 2006 Nov;4(11):1419-1420.
Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointestinal Endoscopy 2005 Oct;62(4):488-498.
Rice T. Surgical therapy for esophageal cancer. Gastroenterology & Hepatology 2006 Apr;2(4):247-248.
Rice TW. Surgery for cancer of the esophagus and esophagogastric junction. In: Castell DO, Richter JE, eds. The esophagus. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Chapter 14. p. 290-314.
Rice TW, McKelvey AA, Richter JE, Baker ME, Vaezi MF, Feng J, Murthy SC, Mason DP, Blackstone EH. A physiologic clinical study of achalasia: should Dor fundoplication be added to Heller myotomy? Journal of Thoracic and Cardiovascular Surgery 2005 Dec;130(6):1593-1600.
Rice TW, Mendelin JE, Goldblum JR. Barrett's esophagus: Pathologic considerations and implications for treatment. Seminars in Thoracic and Cardiovascular Surgery 2005 Winter;17(4):292-300.
Rice TW, Murthy SC. Surgical treatment of benign esophageal diseases. In: Sellke FW, del Nido PJ, Swanson SJ, eds. Sabiston & Spencer surgery of the chest. 7th ed. Philadelphia: Elsevier Saunders, 2005. Volume 1. Chapter 35. p. 583-609.
Rice TW, Blackstone EH. Reply to the editor [Dor fundoplication after myotomy for achalasia: Useful, unnecessary, or harmful?]. Journal of Thoracic and Cardiovascular Surgery 2006 Jul;132(1):217.
Rice TW, Khuntia D, Rybicki LA, Adelstein DJ, Vogelbaum MA, Mason DP, Murthy SC, Blackstone EH. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Annals of Thoracic Surgery 2006 Dec;82(6):2042-2049,2049.e1-e2.
Rice TW. Anastomotic stricture complicating esophagectomy. Thoracic Surgery Clinics 2006 Feb;16(1):63-73.
Rice TW. Esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus. American Journal of Gastroenterology 2006 Oct;101(10):2177-2179.
Rice TW, Mason DP, Murthy SC, Zuccaro G, Jr., Adelstein DJ, Rybicki LA, Blackstone EH. T2N0M0 esophageal cancer. Journal of Thoracic and Cardiovascular Surgery 2007 Feb;133(2):317-324.
Rice TW, Zuccaro G, Jr. Endoscopic esophageal ultrasonography. In: Yeo CJ, ed. Shackelfords surgery of the alimentary tract. 6th ed. Philadelphia: Saunders Elsevier, 2007. Volume 1. Chapter 7. p. 111-127.
Baker ME, Einstein DM, Herts BR, Remer EM, Motta-Ramirez GA, Ehrenwald E, Rice TW, Richter JE. Gastroesophageal reflux disease: integrating the barium esophagram before and after antireflux surgery. Radiology 2007 May;243(2):329-339.
Robert ME, Washington MK, Lee JR, Goldenring JR, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart JA, Lamps LW, Lauwers GY, Lewin D, Lazenby AJ, Montgomery E, Crawford JM. Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. American Journal of Clinical Pathology 2005 Oct;124(4):519-527.
Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, Cameron A, Corley D, Falk G, Goldblum J, Hunter J, Jankowski J, Lundell L, Reid B, Shaheen NJ, Sonnenberg A, Wang K, Weinstein W. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004 Jul;127(1):310-330.
Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology 2006 May;4(5):566-572.
Sharma P, Falk G, Sampliner R. Reply [The long-term efficacy of pneumatic dilation and Heller myotomy for the treatment of achalasia]. Clinical Gastroenterology and Hepatology 2006 Nov;4(11):1420.
Shay S. Esophageal impedance monitoring: the ups and downs of a new test. American Journal of Gastroenterology 2004 Jun;99(6):1020-1022.
Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, Peters J, Castell D. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. American Journal of Gastroenterology 2004 Jun;99(6):1037-1043.
Shay S, Richter J. Direct comparison of impedance, manometry, and pH probe in detecting reflux before and after a meal. Digestive Diseases and Sciences 2005 Sep;50(9):1584-1590.
Shay SS, Lopez R. Impedance monitoring shows that posture and a meal influence gastro-oesophageal reflux composition and frequency. Neurogastroenterology and Motility 2007 Feb;19(2):94-102.
Spechler SJ, Sharma P, Traxler B, Levine D, Falk GW. Gastric and esophageal pH in patients with Barretts esophagus treated with three esomeprazole dosages: A randomized, double-blind, crossover trial. American Journal of Gastroenterology 2006 Sep;101(9):1964-1971.
Topol EJ, Falk GW. A coxib a day wont keep the doctor away. Lancet 2004 Aug 21;364(9435):639-640.
Tutuian R, Vela MF, Shay SS. Esophageal function testing and gastroesophageal reflux testing using multichannel intraluminal impedance. In: Castell DO, Richter JE, eds. The esophagus. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Chapter 7. p. 151-164.
Urba SG, Moon J, Giri PGS, Adelstein DJ, Hanna E, Yoo GH, Leblanc M, Ensley JF, Schuller DE. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. Journal of Clinical Oncology 2005 Jan 1;23(1):88-95.
Vela MF, Richter JE, Wachsberger D, Connor J, Rice TW. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, heller myotomy, and botulinum toxin injection. American Journal of Gastroenterology 2004 Jun;99(6):1029-1036.
Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clinical Gastroenterology and Hepatology 2006 May;4(5):580-587.
Cotton PB, Barkun A, Ginsberg G, Hawes RH, Atkin W, Bjorkman DJ, Dykes C, Elta G, Farrell J, Fleischer D, Ganz R, Glenn T, Janowski D, Johnson D, Kochman M, Kowalski T, Megibow AJ, McQuaid K, Sasa H, Thompson CC, Vargo J, Woods K. Diagnostic endoscopy: 2020 vision. Gastrointestinal Endoscopy 2006 Sep;64(3):395-398.
Zuccaro G, Jr. Tumors of the esophagus. In: Castell DO, Richter JE, eds. The esophagus. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Chapter 13. p. 275-289.
Zuccaro G, Jr., Rice TW, Vargo JJ, Goldblum JR, Rybicki LA, Dumot JA, Adelstein DJ, Trolli PA, Blackstone EH. Endoscopic ultrasound errors in esophageal cancer [Erratum in: Am J Gastroenterol 2005 May;100(5):1216. Zuccaro, Gregory [added]; Rybicki, Lisa [added].]. American Journal of Gastroenterology 2005 Mar;100(3):601-606.
Zuccaro G, Jr. Endoscopic ultrasound classification of esophageal cancer after chemotherapy or chemoradiotherapy. American Journal of Gastroenterology 2006 Jun;101(6):1222-1223.
Vollweiler J, Zuccaro G, Jr. Staging of esophageal cancer. In: Faigel DO, Kochman ML, eds. Endoscopic oncology: gastrointestinal endoscopy and cancer management. Totowa, N.J.: Humana Press, 2006. Chapter 4. p. 31-42.
